These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38826450)

  • 1. Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis.
    Nguyen HN; Jeong Y; Kim Y; Kim YH; Athar H; Castaldi PJ; Hersh CP; Padera RF; Sholl LM; Vivero M; Sharma NS; Yun J; Merriam LT; Yuan K; Kim EY; Brenner MB
    bioRxiv; 2024 May; ():. PubMed ID: 38826450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
    Murray LA; Argentieri RL; Farrell FX; Bracht M; Sheng H; Whitaker B; Beck H; Tsui P; Cochlin K; Evanoff HL; Hogaboam CM; Das AM
    Int J Biochem Cell Biol; 2008; 40(10):2174-82. PubMed ID: 18395486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
    Uhal BD; Kim JK; Li X; Molina-Molina M
    Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.
    Nguyen HN; Noss EH; Mizoguchi F; Huppertz C; Wei KS; Watts GFM; Brenner MB
    Immunity; 2017 Feb; 46(2):220-232. PubMed ID: 28228280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
    Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE
    Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk.
    Zeng C; Wang Q; Liu X; Wang K; Wang C; Ju X; Wang T; Zhou Q; Fu X; Yu J; Wang Y
    Int J Nanomedicine; 2024; 19():1827-1842. PubMed ID: 38414524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
    Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
    PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis.
    Ng B; Dong J; D'Agostino G; Viswanathan S; Widjaja AA; Lim WW; Ko NSJ; Tan J; Chothani SP; Huang B; Xie C; Pua CJ; Chacko AM; Guimarães-Camboa N; Evans SM; Byrne AJ; Maher TM; Liang J; Jiang D; Noble PW; Schafer S; Cook SA
    Sci Transl Med; 2019 Sep; 11(511):. PubMed ID: 31554736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation.
    Wu M; Wang Z; Shi X; Zan D; Chen H; Yang S; Ding F; Yang L; Tan P; Ma RZ; Wang J; Ma L; Ma Y; Jin J
    Respir Res; 2023 Sep; 24(1):222. PubMed ID: 37710230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ.
    Tan Y; Mosallanejad K; Zhang Q; O'Brien S; Clements M; Perper S; Wilson S; Chaulagain S; Wang J; Abdalla M; Al-Saidi H; Butt D; Clabbers A; Ofori K; Dillon B; Harvey B; Memmott J; Negron C; Winarta D; Tan C; Biswas A; Dong F; Morales-Tirado V; Lu X; Singh G; White M; Ashley S; Knight H; Westmoreland S; Phillips L; Carr T; Reinke-Breen L; Singh R; Xu J; Wu K; Rinaldi L; Stoll B; He YD; Hazelwood L; Karman J; McCluskey A; Stine W; Correia I; Gauld S; Levesque MC; Veldman G; Hubeau C; Radstake T; Sadhukhan R; Fiebiger E
    Front Immunol; 2024; 15():1293883. PubMed ID: 38455057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
    Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IPF pathogenesis is dependent upon TGFβ induction of IGF-1.
    Hernandez DM; Kang JH; Choudhury M; Andrianifahanana M; Yin X; Limper AH; Leof EB
    FASEB J; 2020 Apr; 34(4):5363-5388. PubMed ID: 32067272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts.
    Nguyen TH; Nguyen HH; Nguyen TD; Tran VT; Nguyen HA; Pham DV
    Biochem Pharmacol; 2024 Aug; 229():116496. PubMed ID: 39159876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis.
    Kadefors M; Berlin F; Wildt M; Dellgren G; Rolandsson Enes S; Aspberg A; Westergren-Thorsson G
    Front Pharmacol; 2022; 13():953771. PubMed ID: 36120350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
    Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.
    Kurowska-Stolarska M; Hasoo MK; Welsh DJ; Stewart L; McIntyre D; Morton BE; Johnstone S; Miller AM; Asquith DL; Millar NL; Millar AB; Feghali-Bostwick CA; Hirani N; Crick PJ; Wang Y; Griffiths WJ; McInnes IB; McSharry C
    J Allergy Clin Immunol; 2017 Jun; 139(6):1946-1956. PubMed ID: 27746237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.